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Background: Heart failure (HF) is a common, progressive, complex clinical syndrome and a
subset of HF patients has symptoms out of proportion to the resting hemodynamics and left
ventricular ejection fraction (LVEF). Right ventricular (RV) function is a powerful prognostic
factor in HF, but assessing it is a challenge because of the right ventricle's complex geometry.
Objective: The aim of this study was to investigate the clinical application value of RV
outﬂow tract (RVOT) function measured by transthoracic echocardiography in HF patients.
Method: We prospectively investigated 36 chronic HF patients with dilated heart and LV
systolic dysfunction and 21 healthy control subjects (normal ventricular function and ECG,
and no cardiac risk factors). In addition to clinical and conventional echocardiographic
parameters, RVOT size and fractional shortening (RVOT-FS) parameters were analyzed.
Results: The RVOT-FS was less in HF patients than healthy controls (18.8  15.7 vs 55.8  6.7,
p < 0.001) and correlated positively with TAPSE (r = 0.814, p < 0.001) and inversely with SPAP
(r = 0.728, p < 0.001) and functional capacity (r = 0.842, p < 0.001). There was a statistically
signiﬁcant difference in RVOT-FS among the HF subgroups with regard to NYHA functional
capacity (p < 0.001), although there was no statistically signiﬁcant difference with regard to
LVEF.
Conclusion: Although the apparent discordance between LVEF and the degree of functional
impairment in HF is not well understood, it may be explained in part by alterations in RV
function. We found that the RVOT-FS was a noninvasive and easily applicable measure of
RV function and might be used for a comprehensive evaluation and follow-up of HF patients
with a combined assessment of RV by other RV parameters.
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Heart failure (HF) is a common, progressive, complex clinical
syndrome with high morbidity and mortality.1 Decreased
exercise capacity is the main symptom in HF patients;
therefore, the physician should provide an estimation of the
functional class of the patient based on an assessment of the
patient's daily activity and the limitations imposed by the
patient's symptoms of HF. Although imperfect, the New York
Heart Association (NYHA) classiﬁcation has long been used to
categorize HF patients, and this classiﬁcation provides
important prognostic information. Although HF is generally
regarded as a hemodynamic disorder, many studies have
indicated that there is a poor relation between measures of
cardiac performance and the symptoms produced by the
disease. However, a subset of patients with HF has symptoms
out of proportion to the resting hemodynamics. Patients with a
very low left ventricular ejection fraction (LVEF) may be
asymptomatic, whereas patients with preserved LVEF may
have severe disability. The apparent discordance between
LVEF and the degree of functional impairment is not well
understood but may be explained in part by alterations in
ventricular distensibility, valvular regurgitation, pericardial
restraint, cardiac rhythm abnormalities, and left atrial or right
ventricular (RV) function.1–3
For many years, cardiologists were not interested in
studying RV function and the role of the RV in HF. In recent
years, RV function has been found to be a powerful prognostic
factor in HF and pulmonary hypertension (PH),4 but assessing
it is a challenge because of the right ventricle's complex
geometry, its interrelationship with the left ventricle (LV), its
extreme sensitivity to loading conditions and to alterations in
pulmonary pressure, and a limited understanding of underly-
ing mechanisms of right HF.5–7 Due to its widespread
availability, echocardiography is used as the ﬁrst line imaging
modality for assessment of RV size and function; however, a
single widely accepted and generally applicable index of RV
function is not available.5,7 The RV has 3 distinct features, i.e.,
the ‘‘inﬂow’’, ‘‘trabeculated apical’’, and ‘‘outﬂow tract’’
(infundibulum or conus) compartments, with different extent
of contribution to the overall systolic function.8–10 There are
some data to suggest that the myocardium of the RV itself is
intrinsically different to that of the LV.11–13 The RV shortens in
a circumferential direction during the isovolumic contraction
controlled by subepicardial ﬁbers and longitudinally during
the ejection phase controlled by subendocardial ﬁbers. The RV
outﬂow tract (RVOT) has superﬁcial circumferential muscle
ﬁbers, which causes radial RVOT contraction during systole.11
It starts with a short contraction of the inlet region and ends
with the contraction of the RVOT that is of longer duration.
Since the onset of the RV ejection at RVOT occurs 25–50 ms
after the contraction of the inﬂow tract, these result in overall
peristalsis-like ventricular motion.2,14–16 The RVOT function
has been found to correlate closely with other anatomical, long
axis as well as functional parameters and transtricuspid
retrograde pressure gradient.11–13
Although the inlet part of the RV has a greater contribution
to overall RV function compared with the infundibulum,17–19
some studies have reported a possibility of using RVOTmovement or contraction as a marker of RV systolic
function.11–13,20 Therefore, we aimed to evaluate the clinical
and functional signiﬁcance of RVOT in patients with HF.
2. Methods
We prospectively included HF patients. Inclusion criteria
included a diagnosis of chronic HF for at least 12 months.
All patients gave their written consent to participate in this
study. All patients with arrhythmia, infectious disorders,
malignant tumor, previous history of right heart failure or
diagnosis of Group 1 PH (e.g., pulmonary arterial hyperten-
sion), Group 3 PH (PH associated with lung respiratory diseases
and/or hypoxia), Group 4 PH (PH due to chronic thrombotic
and/or embolic disease), and Group 5 PH (PH associated with a
miscellaneous of rare diseases), and poor echocardiographic
window were excluded. In keeping with current guidelines,21
PH was deﬁned using the pre-speciﬁed cut-off of PASP
>50 mmHg at rest. In the present study, the term PH refers
to an increased PASP associated with left heart diseases (Group
2 PH).
The study patients had a clinical diagnosis of HF made on
the basis of compatible clinical presentation and history
combined with documented systolic LV dysfunction (LVEF
<50%) and dilation by transthoracic echocardiography. All
patients were on standard HF therapy. Patients were divided
into 3 groups according to their NYHA functional class (I, no
symptoms with ordinary activity; II, mild limitation of physical
activity and symptoms with ordinary physical activity; III,
marked limitation of physical activity and symptoms with less
than ordinary physical activity; and IV, symptoms with any
physical activity or at rest). The patient groups were compared
to a control group consisting of 21 age- and sex-matched,
healthy control group.
Transthoracic echocardiography was performed by using a
GE Vivid S5 with a 3.0 MHz phased-array transducer. Patients
were examined in the left lateral decubitus position.
The SPAP was estimated by continuous wave Doppler
evaluation of tricuspid regurgitation.22,23
RV long axis function via the tricuspid annular systolic
excursion (TAPSE) was recorded from the apical four-chamber
view with the M-mode cursor positioned at the free wall angle
of the tricuspid valve. The distance between the tricuspid
annulus and the RV apex was measured at end diastole and
end systole of the same cardiac cycle, and TAPSE was
calculated (in millimeters) as the difference between end-
diastolic and end-systolic measurements.24
Two-dimensional echocardiograms of the parasternal
short axis view at the level of the aortic root were obtained
for the RVOT sizes and fractional shortening (RVOT-FS) values.
M-mode recordings of the RVOT were obtained and dimen-
sions were measured at end diastole (onset of the Q wave) and
end systole (end of T-wave) using endocardial leading edge
methodology. RVOT-FS was calculated as the percentage fall in
RVOT diameter in systole with respect to that in diastole using
the same M-mode images, as reported by Lindqvist et al.13
(Fig. 1).
Data were analyzed by SPSS 16.0 (SPSS Inc., Chicago, IL,
USA) software. Continuous variables were expressed as
Table 1 – Comparison of echocardiographic parameters in
patients with and without heart failure. BMI, body-mass
index; TAPSE, tricuspid annular plane systolic excursion;
SPAP, systolic pulmonary artery pressure; LVEF, left
ventricular ejection fraction; LVEDD; left ventricular end-
diastolic diameter; RVOT, right ventricular outflow tract;
RVOT-FS, right ventricular outflow tract fractional short-
ening.
Patients Heart failure
(n = 36)
Control
(n = 21)
p value
Age (years) 60.5  7.7 56.3  10.6 0.086
Sex (male, %) 80.6% 81.0% 0.971
BMI (kg/m2) 28.8  4.0 28.6  3.7 0.892
TAPSE (mm) 15.7  6.0 27.5  3.3 <0.001
SPAP (mmHg) 37.1  8.2 19.1  1.9 <0.001
LVEF (%) 21.5  4.8 66.9  2.8 <0.001
LVEDD (mm) 62.5  4.9 46.9  2.7 <0.001
Diastolic RVOT
size (mm)
39.7  4.9 30.2  3.5 <0.001
RVOT-FS (%) 18.8  15.7 55.8  6.7 <0.001
Fig. 1 – Two-dimensional echocardiogram of the parasternal short axis view at the level of the aortic root showing the right
ventricular outflow tract (RVOT) maximal (‘‘RVOT-es’’ at end systole) and minimal (‘‘RVOT-ed’’ at end diastole) sizes, and
RVOT-FS value using the M-mode images. RVOT, right ventricular outflow tract; RVOT-es, the maximal RVOT size at end
systole; RVOT-ed, the minimal RVOT size at end-diastole; RVOT-FS, RVOT fractional shortening; Ao, aorta; LA, left atrium;
RA, right atrium.
i n d i a n h e a r t j o u r n a l 6 8 ( 2 0 1 6 ) s 1 0 – s 1 4S12mean  standard deviation and categorical variables as
numbers and percentages. Two group comparisons were
performed using an unpaired t-test or Mann–Whitney U-test
according to normality test results, and an analysis of variance
(ANOVA) test with Tukey's Honestly Signiﬁcant Difference
(HSD) post hoc test was used for comparison of three groups.
Nonparametric methods were applied when the distribution
was skewed or the number in a group was below 30. Chi-
square analyses were conducted to compare categorical
variables. Pearson or Spearman correlation coefﬁcients were
calculated in order to assess the associations between the two
continuous variables. p-value less than 0.05 was deﬁned as
statistically signiﬁcant.
3. Results
Thirty-six HF patients (81% men; mean age, 62  8 years)
participated in the study. The subject group was compared to a
control group consisting of 21 asymptomatic healthy control
subjects with a mean age of 56  11 years (Table 1). All 36
patients had undergone coronary angiography and 16 had
unobstructed coronary arteries and no identiﬁable secondary
cause (including no documented infarction by history or the
presence of Q waves satisfying standard ECG criteria of
infarction) and were being treated with a clinical diagnosis
of dilated cardiomyopathy. 20 subjects had angiographically
documented CAD (>50% stenosis in ≥1 coronary arteries) and
had a history of anterior myocardial infarction. The patient
characteristics are detailed in Table 1.The RVOT-FS was less in HF patients than healthy controls
(18.8  15.7 vs 55.8  6.7, p < 0.001) and correlated positively
with TAPSE (r = 0.814, p < 0.001) and inversely with SPAP
(r = 0.728, p < 0.001) and functional capacity (r = 0.842,
p < 0.001) (Table 2). There was a statistically signiﬁcant
difference in RVOT-FS among the HF subgroups with regard
to NYHA functional capacity (p < 0.001), although there was no
statistically signiﬁcant difference with regard to LVEF (Table 3).
Table 2 – Correlation analysis of RVOT-FS with other right
ventricular echocardiographic parameters and functional
capacity. RVOT-FS, right ventricular outflow tract frac-
tional shortening; TAPSE, tricuspid annular plane systolic
excursion; SPAP, systolic pulmonary artery pressure;
RVOT, right ventricular outflow tract; LVEDD; left ventri-
cular end-diastolic diameter; NYHA; New York Heart
Association functional classification.
RVOT-FS r value p value
TAPSE 0.814 <0.001
SPAP 0.728 <0.001
Diastolic RVOT size 0.788 <0.001
LVEDD 0.508 <0.001
NYHA functional capacity 0.842 <0.001
LVEF 0.888 <0.001
Table 3 – Comparison of echocardiographic parameters in
subgroups of heart failure patients with regard to func-
tional capacity. NYHA, New York Heart Association
functional classification; LVEF, left ventricular ejection
fraction; TAPSE, tricuspid annular plane systolic excur-
sion; SPAP, systolic pulmonary artery pressure; LVEDD,
left ventricular end-diastolic diameter; RVOT, right ven-
tricular outflow tract; RVOT-FS, right ventricular outflow
tract fractional shortening.
Heart failure
subgroups
NYHA I &
II (n = 14)
NYHA III
(n = 14)
NYHA IV
(n = 8)
p value
Age (years) 62.4  7.0 56.9  7.6 63.5  7.1 0.072
LVEF (%) 24.6  5.9 20.0  4.2 20.7  3.5 0.072
TAPSE (mm) 21.9  5.2 13.6  3.7 10.9  2.0 <0.001
SPAP (mmHg) 26.4  3.9 35.5  10.2 47.1  16.4 0.016
LVEDD (mm) 59.3  2.8 64.3  4.1 65.3  6.3 0.003
Diastolic RVOT
size (mm)
36.4  3.3 40.2  4.8 44.5  3.5 <0.001
RVOT-FS (%) 34.9  3.3 9.1  2.4 7.6  2.4 <0.001
i n d i a n h e a r t j o u r n a l 6 8 ( 2 0 1 6 ) s 1 0 – s 1 4 S134. Discussion
We found that the RVOT systolic function assessed by RVOT-
FS decreased in HF patients compared to healthy controls, and
more interestingly, RVOT-FS was correlated inversely with
NYHA functional capacity despite LVEF being similar in HF
subgroups.
The majority of the proposed methods of echocardiograph-
ic assessment of RV function are based on volumetric
approximations of the RV. Such approaches have inherent
limitations: (1) because volume-related measures such as
ejection fraction are load dependent and (2) because of the
complex geometry of the RV. The issue of RV geometry is
usually overcome using geometry-independent parameters
such as TAPSE and the Tei index.2,25 However, RVOT-FS has
been shown to be correlated with PH more than TAPSE.13 In the
current study, RVOT size and contraction were correlated with
functional capacity and TAPSE in HF.
Recently, there has been an increasing interest in the RV,
particularly with regard to LV failure.20,26,27 Several studies
have shown that exercise capacity, as measured by peak VO2,
is more closely associated with RV ejection fraction than with
LVEF.26 It has also shown that RV function is an important
predictor of both response to CRT and long-term clinical
outcome of HF patients,28,29 and recommended that routine
assessment of the RV should be considered in the evaluation of
HF patients for CRT. In the current study, we found that RVOT-
FS decreased in HF patients and correlated inversely with
NYHA functional capacity despite similar LVEF in HF sub-
groups. Although the inlet part of the RV has a greater
contribution to overall RV function compared with the
infundibulum,17–19 some studies have reported a possibility
of using RVOT movement or contraction as a marker of RV
systolic function.11–13,22 Lindqvist et al.13 reported that RVOT-
FS moderately correlated with TAPSE, and moderately and
inversely correlated with transtricuspidal Doppler gradient.
Similar to RVOT-FS, Asmer et al.11 reported that RVOT systolic
excursion, which is actually a component of RVOT-FS, is novel,
simple, and promising parameter for assessing RV function.
They speculated that separation of RVOT systolic excursion
values were better compared to RVOT-FS values, due to the
fact that RVOT-FS is affected by LV function as well, whereasLV function has no effect on RVOT systolic excursion.11 In
patients with good LV function, the aorta is pushed anteriorly
in systole, contributing to RVOT-FS even in the presence of
reduced RV function; however, this effect also might provide
positive effect on RV function.
There were a number of limitations to our study. Firstly, the
window for measurement of RVOT size has not been
standardized, and oblique imaging of the RVOT may underes-
timate the fractional shorting value or overestimate its size
echocardiographically. The diameters of RVOT are different at
different sites, when using different methods and in different
body position.5 Again, the endocardial deﬁnition of the
anterior wall is often suboptimal. Secondly, there is lack of a
comparative gold standard technique for assessing global RV
function, such as cardiac catheterization and/or cine magnetic
resonance imaging. Therefore, the association of RVOT-FS
with left-sided ﬁlling pressures and PVR by echo parameters
was not addressed, and absence of measurement of RV
fractional area change remains a major issue. Thirdly, we did
not evaluate the diastolic HF patients. Finally, despite the
NYHA functional classiﬁcation system providing a rapid
assessment of the functional status during physical exertion
in HF patients, it is often heavily reliant on subjective
measurements made by both the clinician and the patient.
Therefore, the other noninvasive tests such as the 6-min
walking test would serve as a benchmark to assess the
functional capacity.30
In conclusion, although the apparent discordance between
LVEF and the degree of functional impairment in HF is not well
understood in some patients, it may be explained in part by
alterations in RV and RVOT function. We demonstrated that
the RVOT-FS was a noninvasive and easily applicable measure
of RV function and might be used for a comprehensive
evaluation and follow-up of HF patients.
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